A recent study revealed ILC2s to be the major source of IL-4 and IL-13 in tumours in a mouse model of colorectal cancer (CRC), and that ILC2-derived IL-4 and IL-13 promote M-MDSC expression both in vitro and in vivo [28]. This evidence concerns the gene IL4 and colorectal carcinoma.